Author details

Skip to Main Content

Full Name

David Wright

Affiliation

ORCID

Career Start Year

2000

Papers

12

H Index

8

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
29544670	Analysis of non-posterior canal benign paroxysmal positional vertigo in patients treated using the particle repositioning chair: A large, single-institution series.	American Journal of Otolaryngology - Head and Neck Medicine and Surgery	2018
26572686	Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin.	Journal of Viral Hepatitis	2016
27140229	Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.	Eur J Gastroenterol Hepatol	2016
24446523	Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.	Journal of Infectious Diseases	2014
22290978	Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C.	Antimicrobial Agents and Chemotherapy	2012
21145839	Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.	Journal of Hepatology	2011
21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	Science	2010
18433307	Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.	Clin Infect Dis	2008
18474492	Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients.	HIV Clinical Trials	2008
14518696	A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.	Antiviral Therapy	2003
11737381	The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant-controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs.	HIV Medicine	2001
10983646	A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).	AIDS	2000

1 - 12 of 12

Stephen J Brown

Co-authored papers 2

Steven Santiago

Co-authored papers 2

Co-authored papers 2

Sharon A Riddler

Co-authored papers 2

Co-authored papers 2

Richard Haubrich

Co-authored papers 2

Ragon Institute of MGH

Co-authored papers 1

Lauren Gianniny

Co-authored papers 1

Co-authored papers 1

Co-authored papers 1

Dawn Loy

Co-authored papers 1

Co-authored papers 1

Constance Shamuyarira Richards

Co-authored papers 1

Robert R Graham

Genentech Inc.

Co-authored papers 1

Cecilia M Shikuma

Co-authored papers 1

Co-authored papers 1

Co-authored papers 1

Co-authored papers 1

Charles Walworth

Co-authored papers 1

Co-authored papers 1

Hendrik Streeck

Co-authored papers 1

Co-authored papers 1

Co-authored papers 1

Edward C Oldfield

Co-authored papers 1

Co-authored papers 1

Co-authored papers 1

Clifford G Wlodaver

Co-authored papers 1

Mary Carrington

Frederick National Laboratory for Cancer Research, National Cancer Institute

Co-authored papers 1

Co-authored papers 1

Nicole F Bernard

Co-authored papers 1

1 - 30